# FDA Inspection 1191632 - C5 Biomedical LLC - November 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/c5-biomedical-llc/85673e56-925e-4dd5-9e48-d341cfaed528
Source feed: FDA_Inspections

> FDA Inspection 1191632 for C5 Biomedical LLC on November 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191632
- Company Name: C5 Biomedical LLC
- Inspection Date: 2022-11-28
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1305066 - 2026-03-02](https://www.keypedia.com/records/fda_inspections/c5-biomedical-llc/1a57a136-43b5-4456-a465-30a1a971fa44)
- [FDA Inspection 1191632 - 2022-11-28](https://www.keypedia.com/records/fda_inspections/c5-biomedical-llc/0b587220-63ed-428b-aefc-34bf1b9276d9)

Company: https://www.keypedia.com/companies/c5-biomedical-llc/f66b3d37-079e-48d9-9fad-62ee2cd56c83

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d